Home

Why Choose Medcrave Mission & Vision Partners & Supporters News & Press Release

Journals eBooks Videos Reprints

Magazines Editors-in-Chief FAQs Contact Us ☰

Breaking the complexity of T2D management with iGlarLixi: a simplified innovation in T2DM management paradigm

: Journal of Diabetes, Metabolic Disorders & Control
: Shambo Samrat Samajdar,¹ Rupak Chatterjee,² Shatavisa Mukherjee,³ Shashank Joshi⁴

PDF Full Text

Keywords

iGlarLixi, insulin glargine, lixisenatide, efficacy, safety, clinical implications

© 2014-2026 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at www.medcrave.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera | Terms and Conditions | Privacy Policy

Testimonials